Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Inhale acquires novel particle formulation technology for lung delivery

Oct. 22, 1999

Technology acquisition broadens and accelerates ICAgen's R&D programs

Oct. 20, 1999

New drug discovery collaboration with Organon announced by Pharmacopeia

Oct. 20, 1999

Glaxo Wellcome makes strides in genetic research

Oct. 20, 1999

Two new photoactivatable, biotin-labeled verapamil analogues useful for studies on P-170

Oct. 13, 1999

Enzo Biochem's HGTV43 achieves high levels of gene delivery to human cells

Oct. 12, 1999

Synthesis and activity of potent, selective sigma1 ligands reported by Taisho

Oct. 8, 1999

Aventis R&T expands drug discovery collaboration with Nanogen

Oct. 5, 1999

Incyte and Schering expand agreement

Oct. 5, 1999

Isis and RPR establish collaboration for antisense target validation

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...